Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Monica Arena is active.

Publication


Featured researches published by Monica Arena.


Colorectal Disease | 2013

Efficacy and acceptability of sodium picosulphate/magnesium citrate vs low-volume polyethylene glycol plus ascorbic acid for colon cleansing: a randomized controlled trial.

Gianpiero Manes; Arnaldo Amato; Monica Arena; S. Pallotta; Franco Radaelli; Enzo Masci

The study compared the efficacy, safety and tolerability of a low‐volume picosulphate/magnesium citrate preparation with that of polyethylene glycol plus ascorbic acid (PEG + ASC) in a randomized clinical trial (RCT).


Digestive and Liver Disease | 2013

Interobserver agreement among endoscopists on evaluation of polypoid colorectal lesions visualized with the Pentax i-Scan technique.

Enzo Masci; Benedetto Mangiavillano; Cristiano Crosta; G. Fiori; Cristina Trovato; P. Viaggi; A. Zambelli; Federico Buffoli; Teresa Staiano; Guido Manfredi; Francesco Manguso; Monica Arena; Tara Santoro; Edi Viale; Pier Alberto Testoni

BACKGROUND AND AIMS Advances in colonoscopy, such as the Pentax i-Scan electronic technique, have the potential to improve the early detection of colorectal cancer. The aim of this multicentre study was to assess the interobserver agreement in the visualization of the surface and margins of colorectal polyps and in distinguishing neoplastic from non-neoplastic polyps. PATIENTS AND METHODS Eight expert endoscopists examined 400 mixed previously recorded images of polyps taken with different Pentax i-Scan settings in order to give an evaluation of the surface of the polyp and regular colonic mucosa, the pit-pattern and the nature of the lesion. RESULTS A total of 400 mixed images of polyps with a diameter >5mm and <10mm were stored for analysis. Overall, there was a Kf agreement of 0.370 (p<0.001) and 0.306 (p<0.001) regarding pit-pattern and margins, respectively. The Kf agreement for the difference between neoplastic and non-neoplastic lesions was of 0.446 (p<0.001). CONCLUSIONS We observed good interobserver agreement in the evaluation of neoplastic and non-neoplastic lesions and poor agreement in the evaluation of pit-pattern and margins. Adequate training is required in order to interpret images acquired with the i-Scan technique.


Journal of gastrointestinal oncology | 2010

Endoscopic sealing of a rectovesical fistula with a combination of an over the scope clip and cyano-acrylate injection

Benedetto Mangiavillano; Andrea Pisani; P. Viaggi; Monica Arena; Enrico Opocher; Maria Mangano; Tara Santoro; Enzo Masci

The risk of anastomotic fistula after colon resection is currently reported to range from 5% to 10%. If the fistula is symptomatic or pauci-symptomatic the best therapy is a diverting ileostomy for 2-3 months with subsequent recanalization only when a radiological contrast study shows that the fistula has disappeared (1). Recently, technological advances in gastrointestinal accessories have led to the development of a novel type of clip, the over the scope (OVESCO®) clip, currently used for organ closure during natural orifice transluminal endoscopic surgery (NOTES) (2), or in particular cases of bleeding of the gastrointestinal tract (3) or deep wall lesions (4).


World Journal of Gastrointestinal Endoscopy | 2015

Role of stenting in gastrointestinal benign and malignant diseases

Benedetto Mangiavillano; Nico Pagano; Monica Arena; Stefania Miraglia; Pierluigi Consolo; Giuseppe Iabichino; Clara Virgilio; Carmelo Luigiano

Advances in stents design have led to a substantial increase in the use of stents for a variety of digestive diseases. Initially developed as a non-surgical treatment for palliation of esophageal cancer, the stents now have an emerging role in the management of malignant and benign conditions as well as in all segments of the gastrointestinal tract. In this review, relevant literature search and expert opinions have been used to evaluate the key-role of stenting in gastrointestinal benign and malignant diseases.


Digestive and Liver Disease | 2015

2-Litre polyethylene glycol-citrate-simethicone plus bisacodyl versus 4-litre polyethylene glycol as preparation for colonoscopy in chronic constipation.

Fabrizio Parente; Cristian Vailati; S. Bargiggia; Gianpiero Manes; Paola Fontana; Enzo Masci; Monica Arena; G. Spinzi; Alessandra Baccarin; Giorgia Mazzoleni; Pier Alberto Testoni

BACKGROUND Chronic constipation is a risk factor of inadequate bowel preparation for colonoscopy; however, no large clinical trials have been performed in this subgroup of patients. AIMS To compare bowel cleansing efficacy, tolerability and acceptability of 2-L polyethylene-glycol-citrate-simethicone (PEG-CS) plus 2-day bisacodyl (reinforced regimen) vs. 4-L PEG in patients with chronic constipation undergoing colonoscopy. METHODS Randomized, observer-blind, parallel group study. Adult outpatients undergoing colonoscopy were randomly allocated to 2-L PEG-CS/bisacodyl or 4-L PEG, taken as split regimens before colonoscopy. Quality of bowel preparation was assessed by the Ottawa Bowel Cleansing Scale (OBCS). The amount of foam/bubble interfering with colonic visualization was also measured. RESULTS 400 patients were enrolled. There was no significant difference in successful cleansing (OBCS score ≤6): 80.2% in the 2-L PEG-CS/bisacodyl vs. 81.4% in the 4-L PEG group. Significantly more patients taking 2L PEG-CS/bisacodyl showed no or minimal foam/bubbles in all colonic segments (80% vs. 63%; p<0.001). 2-L PEG-CS/bisacodyl was significantly more acceptable for ease of administration (p<0.001), willingness to repeat (p<0.001) and showed better compliance (p=0.002). CONCLUSION Split 2-L PEG-CS plus bisacodyl was not superior to split 4-L PEG for colonoscopy bowel cleansing in patients with chronic constipation; however, it performed better than the standard regimen in terms of colonic mucosa visualization, patient acceptance and compliance.


Scandinavian Journal of Gastroenterology | 2014

Upper gastrointestinal active bleeding ulcers: review of literature on the results of endoscopic techniques and our experience with Hemospray

Enzo Masci; Monica Arena; E. Morandi; P. Viaggi; Benedetto Mangiavillano

Abstract Introduction and objectives. Acute gastrointestinal (GI) bleeding can lead from mild to immediately life-threatening clinical conditions. Upper GI bleeding (UGIB) is associated with a mortality of 6–10%. Spurting and oozing bleeding are associated with major risk of failure. Hemospray™ (TC-325), a new hemostatic powder, may be useful in these cases. Aim of this study is to review the efficacy of traditional endoscopic treatment in Forrest 1a-1b ulcers and to investigate the usefulness of Hemospray in these patients. Patients and methods. A MEDLINE search was performed and articles that evaluated hemostatic efficacy and rebleeding rate with traditional endoscopic techniques related to Forrest classification were reviewed. Patients with Forrest 1a–1b ulcers were treated with Hemospray, either as monotherapy or in association with other endoscopic techniques. Primary outcome was immediate hemostasis, secondary outcomes were recurrent bleeding and adverse events related to Hemospray use. Results. Analysis of literature showed that mean initial hemostasis success rate in Forrest 1a–1b ulcers was of 92.8%, and mean rebleeding rate was of 13.3%. We enrolled 13 patients treated with Hemospray. Initial hemostasis was achieved in 100% and we reported three cases of rebleeding. No adverse events occurred. Conclusion. Forrest 1a–1b bleeding ulcer is very difficult to treat. Hemospray appears to be an effective hemostatic therapy for these ulcers. However, additional prospective studies are needed to validate these findings.


Digestive and Liver Disease | 2017

Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours

Monica Arena; Enzo Masci; Leonardo Henry Eusebi; Giuseppe Iabichino; Benedetto Mangiavillano; P. Viaggi; E. Morandi; Lorella Fanti; Antonino Granata; Mario Traina; Pier Alberto Testoni; Enrico Opocher; Carmelo Luigiano

BACKGROUND Hemospray is a new endoscopic haemostatic powder that can be used in the management of upper gastrointestinal bleedings. AIMS To assess the efficacy and safety of Hemospray as monotherapy for the treatment of acute upper gastrointestinal bleeding due to cancer. METHODS The endoscopy databases of 3 Italian Endoscopic Units were reviewed retrospectively and 15 patients (8 males; mean age 74 years) were included in this study. RESULTS Immediate haemostasis was achieved in 93% of cases. Among the successful cases, 3 re-bled, one case treated with Hemospray and injection had a good outcome, while 2 cases died both re-treated with Hemospray, injection and thermal therapy. No complications related to Hemospray occurred. Finally, 80% of patients had a good clinical outcome at 30days and 50% at six months. CONCLUSION Hemospray may be considered an effective and safe method for the endoscopic management of acute neoplastic upper gastrointestinal bleedings.


Gastroenterology Research and Practice | 2016

Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review

Carmelo Luigiano; Giuseppe Iabichino; Leonardo Henry Eusebi; Monica Arena; Pierluigi Consolo; Carmela Morace; Enrico Opocher; Benedetto Mangiavillano

Barretts esophagus is a condition in which the normal squamous lining of the esophagus has been replaced by columnar epithelium containing intestinal metaplasia induced by recurrent mucosal injury related to gastroesophageal reflux disease. Barretts esophagus is a premalignant condition that can progress through a dysplasia-carcinoma sequence to esophageal adenocarcinoma. Multiple endoscopic ablative techniques have been developed with the goal of eradicating Barretts esophagus and preventing neoplastic progression to esophageal adenocarcinoma. For patients with high-grade dysplasia or intramucosal neoplasia, radiofrequency ablation with or without endoscopic resection for visible lesions is currently the most effective and safe treatment available. Recent data demonstrate that, in patients with Barretts esophagus and low-grade dysplasia confirmed by a second pathologist, ablative therapy results in a statistically significant reduction in progression to high-grade dysplasia and esophageal adenocarcinoma. Treatment of dysplastic Barretts esophagus with radiofrequency ablation results in complete eradication of both dysplasia and of intestinal metaplasia in a high proportion of patients with a low incidence of adverse events. A high proportion of treated patients maintain the neosquamous epithelium after successful treatment without recurrence of intestinal metaplasia. Following successful endoscopic treatment, endoscopic surveillance should be continued to detect any recurrent intestinal metaplasia and/or dysplasia. This paper reviews all relevant publications on the endoscopic management of Barretts esophagus using radiofrequency ablation.


World Journal of Gastrointestinal Endoscopy | 2016

Biliary and pancreatic stenting: Devices and insertion techniques in therapeutic endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography

Benedetto Mangiavillano; Nico Pagano; Todd H. Baron; Monica Arena; Giuseppe Iabichino; Pierluigi Consolo; Enrico Opocher; Carmelo Luigiano

Stents are tubular devices made of plastic or metal. Endoscopic stenting is the most common treatment for obstruction of the common bile duct or of the main pancreatic duct, but also employed for the treatment of bilio-pancreatic leakages, for preventing post- endoscopic retrograde cholangiopancreatography pancreatitis and to drain the gallbladder and pancreatic fluid collections. Recent progresses in techniques of stent insertion and metal stent design are represented by new, fully-covered lumen apposing metal stents. These stents are specifically designed for transmural drainage, with a saddle-shape design and bilateral flanges, to provide lumen-to-lumen anchoring, reducing the risk of migration and leakage. This review is an update of the technique of stent insertion and metal stent deployment, of the most recent data available on stent types and characteristics and the new applications for biliopancreatic stents.


Case Reports in Surgery | 2015

The Great Pretender: Rectal Syphilis Mimic a Cancer

Andrea Pisani Ceretti; Matteo Virdis; Nirvana Maroni; Monica Arena; Enzo Masci; Alberto Magenta; Enrico Opocher

Rectal syphilis is a rare expression of the widely recognised sexual transmitted disease, also known as the great imitator for its peculiarity of being confused with mild anorectal diseases because of its vague symptoms or believed rectal malignancy, with the concrete risk of overtreatment. We present the case of a male patient with primary rectal syphilis, firstly diagnosed as rectal cancer; the medical, radiological, and endoscopic features are discussed below.

Collaboration


Dive into the Monica Arena's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Enzo Masci

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pier Alberto Testoni

Vita-Salute San Raffaele University

View shared research outputs
Top Co-Authors

Avatar

Francesco Manguso

University of Naples Federico II

View shared research outputs
Researchain Logo
Decentralizing Knowledge